• Tue news: Pfizer explores sale of hospital drugs unit. FDA declines full approval of Ocaliva. AZ better than expected Q3 results. Pfizer, Lilly telehealth platforms draw scrutiny. 23andMe cutting lays off 40%. See more on our front page

Study adds insight on 'rare but devastating' blood clots after AstraZeneca shot

cafead

Administrator
Staff member
  • cafead   Aug 13, 2021 at 11:32: AM
via A new study gives more details about cases of blood clots in people given AstraZeneca's COVID-19 vaccine, which researchers said are "rare but devastating," CNBC reported.

article source